MONA: Automated retinal screening for disease identification and management

Brief Project Information
Retinal screening becomes part of a regular health checkup for early disease identification and management. Major retinal diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration can now be identified in an early stage. Additionally, a retinal analysis can assess the impact of risk factors – including diabetes, smoking, obesity, high cholesterol, and hypertension.

SDG
More information about the project

The MONA software products enable the automated analysis of retinal images. Retinal screening becomes part of a regular health checkup for early disease identification and management. Major retinal diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration can now be identified in an early stage. Additionally, a retinal analysis can assess the impact of risk factors – including diabetes, smoking, obesity, high cholesterol, hypertension and inactivity – in the general population. It contributes to evidence-based population health programs. Retinal screening is valuable for predicting and preventing diseases.
Sustainability Review

5.0
Average Sustainability Index Average Sustainability Index
is calculated based on
editor rating and all crowd ratings.
Editor's comment for this project's sustainability
The project shows us a great example of how Artificial Intelligence can do to achieve the goal of good health and well-being. Retinal screening is non-invasive, quick and relatively more accessible to people with lower income. By taking retinal screening as a method to monitor health conditions, people may be alerted earlier, physicians may be assisted and remote diagnosing may be further promoted.
Rate this project's sustainability index and leave a comment

Do not exceed 500 characters.
Crowd ratings on the project's sustainability